Therapeutic options for intermediate-advanced hepatocellular carcinoma |
| |
| Authors: | Zhang Zong-Ming Guo Jin-Xing Zhang Zi-Chao Jiang Nan Zhang Zhen-Ya Pan Li-Jie |
| |
| Affiliation: | Zong-Ming Zhang,Jin-Xing Guo,Zi-Chao Zhang,Nan Jiang,Zhen-Ya Zhang,Li-Jie Pan,Department of General Surgery,Digestive Medical Center,The First Affiliated Hospital,School of Medicine,Tsinghua University,Beijing 100016,China |
| |
| Abstract: | Hepatocellular carcinoma (HCC) is one of the most common malignancies, ranking the sixth in the world, with 55% of cases occurring in China. Usually, patients with HCC did not present until the late stage of the disease, thus limiting their therapeutic options. Although surgical resection is a potentially curative modality for HCC, most patients with intermediate-advanced HCC are not suitable candidates. The current therapeutic modalities for intermediate-advanced HCC include: (1) surgical procedures, such ... |
| |
| Keywords: | Hepatocellular carcinoma Intermediateadvanced Surgical procedure Interventional treatment Molecularly targeted therapy |
| 本文献已被 CNKI 维普 PubMed 等数据库收录！ |
|
